Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China
· Delayed Price · Currency is CNY 19.47
+0.20 (1.04%)
Apr 30, 2025, 3:00 PM CST
SHA:603896 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 155.96 | 174.71 | 254.48 | 277.78 | 200.83 | 151.71 | Upgrade
|
| Depreciation & Amortization | 75.47 | 75.47 | 76.22 | 64.38 | 53.9 | 43.34 | Upgrade
|
| Other Amortization | 29.12 | 29.12 | 23.77 | 16.71 | 11.93 | 11.36 | Upgrade
|
| Loss (Gain) From Sale of Assets | -8.81 | -8.81 | -0.17 | -0.07 | -0.03 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.02 | 0.02 | 0.03 | 0.06 | 0 | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | -7.41 | -7.41 | -3.95 | -3.28 | 5.49 | -3.87 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.1 | -0.1 | -1.22 | 1.57 | 0.78 | 0.46 | Upgrade
|
| Other Operating Activities | 60.27 | 20.57 | 16.9 | 10.55 | 9.93 | 11.87 | Upgrade
|
| Change in Accounts Receivable | -34.93 | -34.93 | -18.97 | -16.19 | -27.9 | -18.38 | Upgrade
|
| Change in Inventory | -21.72 | -21.72 | -10.08 | -48.69 | 0.32 | 10.72 | Upgrade
|
| Change in Accounts Payable | -13.52 | -13.52 | -22.69 | 38.69 | 36.4 | 30.42 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | 4.39 | 18.74 | Upgrade
|
| Operating Cash Flow | 234.38 | 213.44 | 315.06 | 341.28 | 296.7 | 256.36 | Upgrade
|
| Operating Cash Flow Growth | -17.91% | -32.25% | -7.69% | 15.03% | 15.74% | 23.30% | Upgrade
|
| Capital Expenditures | -407.56 | -507.06 | -414.54 | -182.6 | -161.63 | -64.98 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.38 | 227.58 | 0.11 | 0.24 | 0.05 | - | Upgrade
|
| Cash Acquisitions | - | - | -0.01 | - | - | - | Upgrade
|
| Divestitures | - | - | - | -1.05 | - | - | Upgrade
|
| Investment in Securities | -67.83 | 37.12 | -886.89 | 95.55 | -74.6 | 151.93 | Upgrade
|
| Other Investing Activities | 2.62 | 2.6 | 2.54 | 2.47 | 2.45 | 2.7 | Upgrade
|
| Investing Cash Flow | -469.39 | -239.76 | -1,299 | -85.39 | -233.72 | 89.65 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 661.94 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 430.51 | 737.44 | - | - | 351.5 | Upgrade
|
| Total Debt Issued | 295.35 | 430.51 | 737.44 | 661.94 | - | 351.5 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.02 | - | Upgrade
|
| Long-Term Debt Repaid | - | -590.9 | -609.58 | -9.98 | -5.52 | -10.01 | Upgrade
|
| Total Debt Repaid | -575.9 | -590.9 | -609.58 | -9.98 | -5.54 | -10.01 | Upgrade
|
| Net Debt Issued (Repaid) | -280.54 | -160.38 | 127.86 | 651.96 | -5.54 | 341.49 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -2.1 | -173.13 | Upgrade
|
| Common Dividends Paid | -83 | -83 | -92.78 | -61.12 | -47.51 | -49.58 | Upgrade
|
| Other Financing Activities | 30.52 | - | 255 | -255 | 0.9 | -1.17 | Upgrade
|
| Financing Cash Flow | -333.03 | -243.38 | 290.08 | 335.84 | -54.24 | 117.62 | Upgrade
|
| Net Cash Flow | -568.04 | -269.7 | -693.64 | 591.73 | 8.74 | 463.62 | Upgrade
|
| Free Cash Flow | -173.18 | -293.62 | -99.48 | 158.68 | 135.07 | 191.38 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 17.48% | -29.42% | 64.37% | Upgrade
|
| Free Cash Flow Margin | -26.99% | -42.45% | -12.68% | 19.14% | 17.61% | 30.09% | Upgrade
|
| Free Cash Flow Per Share | -0.87 | -1.48 | -0.51 | 0.82 | 0.71 | 1.04 | Upgrade
|
| Cash Income Tax Paid | 39.45 | 39.45 | 46.41 | 51.43 | 64.36 | 44.66 | Upgrade
|
| Levered Free Cash Flow | -157.35 | -370.44 | -198.9 | -24.34 | 12.62 | 111.99 | Upgrade
|
| Unlevered Free Cash Flow | -148.96 | -361.21 | -183.46 | -16.19 | 18.97 | 119.31 | Upgrade
|
| Change in Net Working Capital | -80.78 | 34.66 | -5.4 | 63.71 | 4.81 | -23.53 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.